Browsing by Author Gloss, B

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2015Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancerColvin, Emily; Howell, Viive; Yuen, Samuel; Brown, Laura; Chang, David K.; et al, Various; Gloss, B; Hacker, Neville F.; Jones, Marc; Moran-Jones, Kim; Murali, Rajmohan; Scarlett, C J; Spong, Suzanne; Wong, Carol; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteConnective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer, Oncotarget, vol.6, 42, 2015,pp 44551-44562
2008The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitrode Fazio, Anna; Murali, Rajmohan; Scolyer, Richard; Scurr, Lyndee; Barton, C; Davies, Michael; et, al; Gloss, B; Henderson, Michelle; O'Brien, P; Patterson, K I; Saunders, D; Scurry, J; Smith, Alison N.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro, British Journal of Cancer, vol.98,(6),2008,pp 1085-1093
2010MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcomeByrne, Jennifer; deFazio, Anna; Emmanuel, Catherine; Fanayan, Susan; Murali, Rajmohan; Gloss, B; Hacker, Neville F.; Hardy, Jayne; Maleki, Sanaz; O'Brien, Philippa M.; Scurry, James P.; Sutherland, Robert L.; Children's Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Northern Clinical School: Kolling Institute; Central Clinical School: PathologyMAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome, BMC Cancer, vol.10, 497,pp 1-11
2014Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasmaArmstrong, Nicola Joy; Clark, Susan; Gloss, B; Hacker, Neville F.; Kaplan, Warren; Lin, Vita ap; Mangs, Helena; Nair, S; Navin, Tina; Samimi, Goli; Sutherland, R; Warton, Kristina; Ying, Kevin; Mathematics & StatisticsMethylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma, BMC Genomics, vol.15, 476, 2014,pp 1-13
2015Unexpected features of the dark proteomeSabir, Kenneth; Buckley, Michael J.; et al, .; Gloss, B; Hammang, Christopher; Heinrich, Julian; Perdigao, Joao; Rost, Burkhard; Signal, Beth; Stolte, Christian; Tabor, Bruce; MedicineUnexpected features of the dark proteome, Proceedings of the National Academy of Sciences of the United States of America (PNAS), vol.112, 52, 2015,pp 15898-15903